Efficacy and Tolerability of ABB I5 Prebiotic and ABB C22 Postbiotics for the Management of Constipation and Gastrointestinal Well-being: a Pilot Trial

Inclusion Criteria: * Subjects who require hospitalization * Constipation defined as the Rome IV criteria for constipation * Patients with the ability to take the study product orally Exclusion Criteria: * History of allergy, idiosyncrasy, hypersensitivity or adverse reactions to the active principle or to any of the excipients. * History or evidence of any medical conditions or medication used that, in the opinion of the principal investigator, could affect the safety of the subjects or interfere with the study evaluations * Patients last palliative care en stage of "end of life" or "terminal" * Amytriptilin (anti-depressive) and masalazine (anti-inflammatory) treatment * Laxatives * Antibiotic treatment in the previous 2 weeks * Patients with IBS or any other gastrointestinal conditions that maybe the cause of the constipation